Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$433K Buy
2,658
+3
+0.1% +$537 0.03% 149
2024
Q3
$519K Sell
2,655
-5
-0.2% -$921 0.04% 136
2024
Q2
$461K Sell
2,660
-22
-0.8% -$3.66K 0.03% 149
2024
Q1
$454K Buy
2,682
+1,095
+69% +$205K 0.04% 160
2023
Q4
$313K Sell
1,587
-31
-2% -$5.49K 0.03% 194
2023
Q3
$282K Sell
1,618
-190
-11% -$34.5K 0.03% 197
2023
Q2
$311K Sell
1,808
-216
-11% -$37.3K 0.04% 180
2023
Q1
$337K Buy
2,024
+342
+20% +$56.1K 0.05% 108
2022
Q4
$246K Buy
1,682
+1
+0.1% +$148 0.04% 123
2022
Q3
$249K Hold
1,681
0.05% 102
2022
Q2
$289K Sell
1,681
-2
-0.1% -$346 0.06% 90
2022
Q1
$317K Buy
1,683
+121
+8% +$23.9K 0.06% 99
2021
Q4
$381K Hold
1,562
0.07% 88
2021
Q3
$303K Sell
1,562
-118
-7% -$23.8K 0.07% 104
2021
Q2
$313K Buy
1,680
+15
+0.9% +$2.6K 0.07% 89
2021
Q1
$262K Buy
+1,665
New +$264K 0.06% 92

Other funds holding ZTS

Geller Advisors's ZTS Position: Q4 2024 in Review

Geller Advisors increased its Zoetis (ZTS) stake by 0.11% in Q4 2024, buying an estimated $537 and bringing the position to 2,658 shares worth $433K. The position accounts for 0.03% of the portfolio, ranked #149.

Geller Advisors first reported a position in ZTS in Q1 2021 and has held it in 16 quarters since. The position peaked at $519K in Q3 2024. 1,870 funds tracked by Wall St. Rank hold ZTS as of Q4 2024.

  • Geller Advisors held 2,658 shares of Zoetis worth $433K as of Q4 2024.
  • Geller Advisors bought 3 Zoetis shares in Q4 2024, an estimated $537.
  • Zoetis made up 0.03% of Geller Advisors's portfolio in Q4 2024, its #149 holding.
  • Geller Advisors first reported a position in Zoetis in Q1 2021 and has held it in 16 quarters since.
  • Geller Advisors's Zoetis position peaked at $519K in Q3 2024.
  • 1,870 funds tracked by Wall St. Rank held Zoetis as of Q4 2024.

Based on Geller Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.